R1 RCM unveils 2023 outlook

R1 RCM reaffirmed its 2022 guidance and unveiled its 2023 outlook in a Jan. 5 news release. 

2022 full-year guidance:

  • Revenue of $1.79 billion to $1.8 billion
  • GAAP operating loss of $8 million to $13 million
  • Adjusted EBITDA of $420 million to $425 million

2023 expectations:

  • Revenue of $2.28 billion to $2.33 billion
  • GAAP operating income of $115 million to $140 million
  • Adjusted EBITDA of $595 million to $630 million

"As we head into 2023, we are focused on executing our strategic plan, including advancing our technology investments and driving our best-in-class commercial engine to deliver value for our customers and team members," CEO Lee Rivas said in the release. 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars